Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Budesonide Nasal spray suspension 64mcg

Approval Number

SIN14029P

Drug Name

Budesonide Nasal spray suspension 64mcg

Product Name

Budesonide Nasal spray suspension 64mcg

Approval Date

October 11, 2011

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SPRAY, SUSPENSION

Route of Administration

NASAL

Medical Information

ATC Code

R01AD05

ATC Item Name

budesonide

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

Laboratorio Aldo-Union S.L.

Active Ingredients

Ingredient Name

Budesonide micronized

Strength

64.0 mcg/dose

Drug MonographBudesonide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Budesonide Nasal spray suspension 64mcg - HSA Approval | MedPath